Novel Agents and Combinations in Hodgkin Lymphoma
0 Mga view
• 07/09/23
0
0
I-embed
administrator
Mga subscriber
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento